PPA-induced autism-like rats administered with MgB (at all doses) exhibited a significant increase in the expression levels of BDNF, GAP, ICAM, PSD-93, and PSD-95 in the brain and decreased GFAP expression, compared to the control group. Here, GFAP is linked to autism.